Back to Search Start Over

China grants conditional approval for Merck's COVID-19 drug

Source :
Xinhua Economic News. January 2, 2023
Publication Year :
2023

Abstract

BEIJING, January 3, 2023 (Xinhua via COMTEX) -- China has activated special approval procedures and granted conditional approval for the import registration of Merck's COVID-19 treatment Molnupiravir, the National Medical [...]

Details

Language :
English
Database :
Gale General OneFile
Journal :
Xinhua Economic News
Publication Type :
News
Accession number :
edsgcl.732027902